欢迎您访问上海体育学院运动科学学院!

师资队伍

首页 > 师资队伍 > 正文

刘龙华

发布者:  时间:2020-09-21 11:30:13  浏览:

                                                 

 

1.个人基本信息

       刘龙华,副教授,硕导。主要从事运动干预与肥胖、糖尿病及动脉粥样硬化等慢性疾病的分子机制研究。目前为止,共发表学术文章13篇 (其中SCI论文:10篇):以第一作者发表在 Diabetes (IF2019=7.72, 中科院1区顶刊)Cell death and disease (IF2019=6.304);Oxidative Medicine and Cellular longevity (IF2019=5.076)等国际知名期刊上8篇。担任 Scientific Reports, Cellular&Molecular Biology, Journal of Cellular and Molecular Medicine 等国际期刊的审稿专家。  

欢迎感兴趣的研究生和本科生加入。联系方式:liulonghua@sus.edu.cn.

 

2.教育和工作经历

 

2017-2020  哥伦比亚大学 (ColumbiaUniversity) , 病理与细胞生物学, 博士后  

2013-2016  弗吉尼亚理工大学 (Virginia Tech),   人类营养与健康,     博士  

2010-2013  清华大学,                          生物学               硕士  

2006—2010, 北京交通大学,                      生物医学工程,       本科  

 

3. 主要学术成果

 

  1. Longhua Liu1; Lihong Fan1;     Michelle Chan; Michael J. Kraakman; Jing Yang; Yong Fan; Nikki Aaron;     Qianfen Wan; Maria Alicia Carrillo-Sepulveda; Alan R Tall, Ira Tabas,     Domenico Accili and Li Qiang*. PPARg deacetylation confers     the antiatherogenic effect and improves endothelial function in diabetes     treatment. Diabetes. 2020;69:1793-1803.(IF2019=7.72, 中科院1区,顶刊)

  2. L Liu, P     Zou, L Zheng, L E Linarelli, S Amarell, A Passaro, D Liu andZ     Cheng*. Tamoxifen Reduces Fat Mass by Boosting Reactive Oxygen Species. Cell Death and Disease 2015; 6, e1586 IF2019=6.304,     中科院2区)

  3. P Zou1, L Liu1,     L Zheng, K Payne, M Manjili, M Idowu, J Zhang, E Schmelz, Z Cheng*.     Coordinated upregulation of mitochondrial biogenesis and turnover in     breast cancer cells: the role of dynamin related protein-1 and implication     for breast cancer treatment. Oxidative Medicine and Cellular Longevity     2016. 2016: 4085727 IF2019=5.076,

  4. Maria Namwanje1, Longhua     Liu1, Michelle Chan, Nikki Aaron, Michael J. Kraakman, Li     Qiang*. The depot-specific and essential roles of CBP/p300 in regulating     adipose plasticity. Journal of Endocrinology 2019; 240 (2):257-269 IF2019=4.041, 中科院2区)

  5. Zou P1, Liu L1, Zheng L, Liu L, Stoneman RE, Cho A, Emery A, Gilbert ER,Cheng Z*. Targeting FoxO1 with AS1842856 Suppresses Adipogenesis. Cell Cycle 2014;13:3759-67.

  6. L Liu, L     Zheng, P Zou, J Brooke, C Smith, YC Long, F Almeida, D Liu and ZCheng*.     FoxO1 antagonist suppresses autophagy and lipid droplet growth in     adipocytes. Cell Cycle 2016; 15:2033-41; PMID: 27260854 DOI:     10.1080/ 15384101. 2016. 1192732.

  7. Longhua Liu, Zhipeng Tao, Louise D Zheng, Joseph P Brooke, Cayleen MSmith,     Dongmin Liu, Yun Chau Long and Zhiyong Cheng*. FoxO1 interacts with     transcription factor EB and differentially regulates mitochondrial     uncoupling proteins via autophagy in adipocytes. Cell Death Discovery     (2016) 2, 16066.

  8. Liu LH, Xie JY, Guo WW, Wu GY, Chen ZF, Yi JY, Zhang L, Zhang ZJ, Li Z*.Evodiamine activates AMPK and     promotes adiponectin multimerization in 3T3-L1 adipocytes. JAsian Nat Prod Res.2014; 16:1074-83.

  9. Liu L,     Zheng LD, Donnelly SR, Emont MP, Wu J, Cheng Z. Isolation of Mouse Stromal     Vascular Cells for Monolayer Culture.Methods Mol Biol. 2017;1566:9-16.

  10. Liu L.,     Cheng Z. Forkhead Box O (FoxO) Transcription Factors in Autophagy,     Metabolic Health, and Tissue Homeostasis. In: Turksen K. (eds) Autophagy     in Health and Disease. Stem Cell Biology and Regenerative Medicine.     2018.Humana Press, Cham.

  11. L Zheng, L Linarelli, L Liu, S     Wall, M Greenawald, R Seidel, P Estabrooks, F Almeida* and Z Cheng*.     Insulin resistance is associated with epigenetic and genetic regulation of     mitochondrial DNA in obese humans. Clinical Epigenetics. 2015;     7:60.

  12. Tao Z, Liu L, Zheng LD, Cheng Z. Autophagy in Adipocyte     Differentiation.Methods Mol Biol.     2017 Aug 17. doi: 10.1007/7651_2017_65.

  13. M Chan, YC Lim, J Yang, M Namwanje, L Liu, L Qiang. Identification of a natural     beige adipose depot in mice. Journalof Biological Chemistry.2019. jbc. RA118. 006838

 

 

 

 

    Copyright © 上海体育学院 运动科学学院            上海市杨浦区恒仁188号 邮编:200438 电话:(86-21)65507356